- Investopedia•10 hours ago
The DEA has approved Syndros, an oral drug for chemotherapy and AIDs patients, as a Schedule II drug.
- Zacks•11 hours ago
Allergan plc (AGN) recently announced that its marketed drug Restasis (cyclosporine ophthalmic emulsion) 0.05% is now available in multidose bottles in the U.S.
- Benzinga•12 hours ago
Share repurchases by S&P 500 member firms were solid last year, but declined from the totals seen in each of the previous two years. Still, the PowerShares BuyBack Achievers Fund (ETF) (NYSE: PKW ) returned ...
AGN : Summary for Allergan plc Ordinary Shares - Yahoo Finance
Allergan plc (AGN)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||233.00 - 237.20|
|52 Week Range||184.50 - 281.28|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||6.16|
|Dividend & Yield||2.80 (1.19%)|
|1y Target Est||N/A|